|
Match
|
Document |
Document Title |
|
|
US20120009133 |
POLY (NON-CONJUGATED DIENE) BASED SUNSCREENS
A poly(non-conjugated diene) based sunscreen has a plurality of repeating units where each repeating unit has at least one UV absorbing chromophore that is situated between and connected by chains...
|
|
|
US20110230678 |
ORGANIC FRAMEWORK
Disclosed is an organic framework including: planar layers formed by successively connecting building blocks arranged in the vicinity of each other, in which each of the building blocks includes...
|
|
|
US20130012591 |
PROPHYLAXIS OF SKIN CANCER WITH RETINAMIDES
Provided in certain embodiments herein are methods of prophylaxis of skin cancer in individuals having a heightened risk of skin cancer with a fenretinide agent.
|
|
|
US20120219538 |
STABILIZED PROTEIN FORMULATIONS AND USE THEREOF
The present invention is directed to stable protein formulations, related methods and uses thereof. In particular, the invention relates to a method of stabilizing therapeutic proteins in aqueous...
|
|
|
US20130089508 |
COMPOSITIONS FOR ENHANCING NAIL HEALTH
The present invention is directed to compositions and methods for enhancing the health of nails and cuticles in a mammal, including humans. The compositions may be administered topically to the...
|
|
|
US20120004463 |
RESOLUTION OF 4,5-DIMETHOXY-1-(METHYLAMINOMENTHYL)-BENZOCYCLOBUTANE
A method of resolving an important chemical intermediate, 4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane, comprises the following steps: reacting its two enantiomers of...
|
|
|
US20120108848 |
PROCESS FOR RESOLUTION OF 1-(3-HYDROXYPHENYL)-2-METHYLAMINO ETHANOL
Resolution of the title compound to its active isomer (R)-1-(3-hydroxyphenyl)-2-methylamino ethanol with (R)-naproxen as a resolving agent.
|
|
|
US20110086818 |
METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITUS
The invention features methods, compositions, and kits for selective inhibition of pain-and itch sensing neurons (nociceptors and pruriceptors) by drug molecules of small molecule weight, while...
|
|
|
US20120225144 |
Herbal Supplement Prepared From Geranium
An extraction method for extracts of Geranium or Pelargonium with improved methylhexaneamine content is provided. The method involves separating the oil phase from the aqueous phase; concentrating...
|
|
|
US20120264719 |
DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
|
|
|
US20120022294 |
Axomadol or a Metabolite Thereof for Use in the Treatment of Irritable Bowel Syndrome
The invention relates to axomadol or a metabolite thereof for use in the treatment of irritable bowel syndrome.
|
|
|
US20080139831 |
Water Tolerant Emulsion Stabilizers
An emulsion stabilizer is disclosed having a water tolerance value of between more than about 1.0 and equal or less than about 11.0.
|
|
|
US20120078015 |
Chemical Installation
According to the present invention, a chemical installation is provided. The chemical installation comprises A first unit for providing a first aqueous waste stream comprising nitrobenzene; At...
|
|
|
US20120277180 |
Cofactors and Methods for Use for Individuals
Provided herein are methods and systems for identifying one or more cofactors such as vitamins for individuals based on the genetic makeup of the individual by detecting the presence or absence of...
|
|
|
US20120178704 |
PREVENTION AND TREATMENT OF COLON CANCER
Stilbene compounds for the prevention and treatment of colon cancer or colon inflammation and methods of using same are provided.
|
|
|
US20090021160 |
MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE, METHOD FOR PRODUCING SAME AND ORGANIC ELECTROLUMINESCENT DEVICE
A material for an organic electroluminescence device which can be a cis-isomer or a trans-isomer of structural isomers, the content of the trans-isomer being more than that of the cis-isomer. The...
|
|
|
US20100331416 |
Use of Monochlorourea to Treat Industrial Waters
The present invention comprises a method for controlling (e.g. inhibiting) or killing microorganisms in an aqueous environment. The method includes the addition of an effective amount of...
|
|
|
US20120148690 |
SKIN BARRIER FUNCTION RECOVERY ACCELERATOR
A novel skin barrier function recovery acceleration method and accelerator are provided. The present invention provides a skin barrier function recovery accelerator that comprises a TRPA1 agonist...
|
|
|
US20120329661 |
Isotope Labeling-Assisted Quantification (iLAQ) of Biological Compounds
The present invention relates to a plurality of isotopically labeled compounds (“tag isotopomers”) and individual labeled compounds, which are useful for labeling samples of analytes, such as bio...
|
|
|
US20120115723 |
Ballast Water Treatment System
A composition for treating waters, e.g. ballast water or injection water for oil recovery, to kill in-situ aquatic invasive species comprises at least one biocide capable of killing both animal and...
|
|
|
US20130023056 |
EARLY DETECTION OF RECURRENT BREAST CANCER USING METABOLITE PROFILING
A monitoring test for recurrent breast cancer with a high degree of sensitivity and specificity is provided that detects the presence of a panel of multiplicity of biomarkers that were identified...
|
|
|
US20130059005 |
BUPROPION HYDROBROMIDE POLYMORPHS
Polymorphous and amorphous forms of bupropion hydrobromide are described.
|
|
|
US20120270296 |
ISOTOPE-DOPED NANO-STRUCTURE AND ISOTOPE LABELED STRUCTURE USING THE SMAE
An isotope-doped nano-structure is provided. The isotope-doped nano-structure includes at least one isotope-doped nano-structure segment having at least two isotopes of the element. The at least...
|
|
|
US20110251289 |
NEW COMPOUNDS FOR THE TREATMENT OF CANCER
The invention provides a method of preparing the stereoisomers of 1,11-diamino-6-aza-undecane-2,4,8,10-tetraol.
|
|
|
US20110123482 |
Methods of Treating Neurological Autoimmune Disorders with Cyclophosphamide
Described herein are methods for treating neurological autoimmune disorders in which the treatment method includes administering an immunoablative agent to eliminate most or essentially all...
|
|
|
US20120172387 |
OPIOIDS FOR THE TREATMENT OF THE RESTLESS LEG SYNDROME
The present invention relates to an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with restless leg syndrome (RLS).
|
|
|
US20110319516 |
RELEASE AGENT PARTITION CONTROL IN IMPRINT LITHOGRAPHY
Release agents with increased affinity toward nano-imprint lithography template surfaces interact strongly with the template during separation of the template from the solidified resist in a...
|
|
|
US20130047849 |
Organic Porous Materials Comprising Shape-Persistent Three-Dimensional Molecular Cage Building Blocks
Porous bulk materials formed of shape-persistent, non-collapsible, three-dimensional molecular cage building blocks are presented that are useful for a variety of applications including gas...
|
|
|
US20110201688 |
N,N'-DI-P-BROMOPHENYL GUANIDINE TREATMENT FOR STROKE AT DELAYED TIMEPOINTS
1,3 di-o-tolylguanidine (DTG) was examined as anti-stroke drug with a broad therapeutic window. DTG activates sigma 1 and 2 receptors. Administration of DTG at 24 hours post-stroke to rats reduces...
|
|
|
US20120196894 |
NOVEL TRPA1 ANTAGONISTS
The present invention relates to compositions and methods that modulate at least one TRP family member. Specifically, the present invention relates to novel TRPA1 antagonists and their use in the...
|
|
|
US20120021044 |
Novel Cationic Lipid, A Preparation Method of the Same and A Delivery System Comprising the Same
The present invention provides a novel cationic lipid, a preparation method of the same and a delivery system comprising the same. The cationic lipid of the present invention is used for the...
|
|
|
US20090060922 |
Acetamide Stereoisomer
The compound of formula (I) is a water-stable, long acting β2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible ...
|
|
|
US20120101087 |
Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins
The present invention relates to, in part, novel bisphenol compounds useful for the recognition, attachment and growth of unwanted biologics on natural and manmade surfaces. Another aspect of the...
|
|
|
US20120014976 |
COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSES TO VACCINES
The disclosure provides adjuvants, immunogenic compositions, and methods useful for vaccination and immune response. In particular, the disclosure provides a class of adjuvants comprising cationic...
|
|
|
US20110275645 |
Small Molecules for Inhibition of Protein Kinases
The invention provides compounds that inhibit protein kinases, prodrugs of the compounds, intermediates and methods of synthesizing the compounds and/or prodrugs, pharmaceutical compositions...
|
|
|
US20120046256 |
Lipolytic Methods for Regional Adiposity Comprising Salmeterol or Formoterol
Compositions, formulations, methods, and systems for treating regional fat deposits comprise contacting a targeted fat deposit with a composition comprising long acting beta-2 adrenergic receptor...
|
|
|
US20130011474 |
MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release pharmaceutical dosage forms containing...
|
|
|
US20120201889 |
MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release pharmaceutical dosage forms containing...
|
|
|
US20110262527 |
CATIONIC LIPIDS AND METHODS OF USE
The present invention provides compositions comprising cationic lipids, liposomes and nucleic acid-lipid particles comprising the cationic lipids, and methods of using such compositions, liposomes,...
|
|
|
US20110269689 |
HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS
High penetration compositions (HPC) of a parent compound, which are capable of crossing biological barriers with high penetration efficiency. The HPCs are capable of being converted to parent drugs...
|
|
|
US20110065705 |
Compositions and Methods of Treating Cell Proliferation Disorders
The invention relates to compounds and methods for treating cell proliferation disorders.
|
|
|
US20120121707 |
Tolbutamide Particle And Preparing Method Thereof And Method Of Reducing A Blood Glucose
A method for preparing a tolbutamide particle is provided. The method comprises steps of mixing a bulk drug of tolbutamide with a supercritical fluid to form a supercritical mixture; and expanding...
|
|
|
US20110294759 |
Once daily formulations of tetracyclines
Disclosed are once-daily formulations containing tetracyclines, especially doxycycline. Such formulations are useful, for instance, for the treatment of collagenase destructive enzyme-dependent...
|
|
|
US20120134933 |
USE OF HIGH-DOSES OF MONOMERIC CONTRAST MEDIUM CONTAINING IODINE IN X-RAY DIAGNOSTICS, IN PARTICULAR IN INTERVENTIONAL X-RAY DIAGNOSTICS AND IN RADIATION THERAPY ASSISTED BY CONTRAST MEDIA CONTAINING IODINE
The invention relates to a diagnostic or therapeutic composition comprising a monomeric X-ray contrast medium containing iodine, in particular iopromide, for use in an X-ray assisted diagnosis or...
|
|
|
US20110189094 |
BIOLOGICAL METHOD FOR IN VIVO TRACKING OF MOLECULES AFFECTING CELLULAR MIGRATION
Cellular migration is a normal part of the normal development of the human being and, in certain pathologies, its alteration damages physiological performance, so that it is necessary to learn...
|
|
|
US20110251196 |
Modulators of G Protein-Coupled Receptor 88
The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled...
|
|
|
US20110245264 |
Modulators of G Protein-Coupled Receptor 88
The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled...
|
|
|
US20110281872 |
COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCER
The invention relates to compositions and methods for the treatment and prevention of cancer and other cell proliferative disorders.
|
|
|
US20110065766 |
METHODS OF USE OF ANTIVIRAL COMPOUNDS
The present invention relates, in part, to methods of treatment, prevention, and inhibition of viral disorders. In one aspect, the present invention relates to inhibition of the M2 proton channel...
|
|
|
US20110065762 |
METHODS OF USE OF ANTIVIRAL COMPOUNDS
The present invention relates, in part, to methods of treatment, prevention, and inhibition of viral disorders. In one aspect, the present invention relates to inhibition of the M2 proton channel...
|